Ohio 136th General Assembly Status: Passed Senate 1 D cosponsors

SB 160 — Regards prescription drugs and medication switching

Last action — Introduced

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has passed the Senate. Introduced April 01, 2025. It now moves to the second chamber.

Next likely step: consideration and a floor vote in the House.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Stalled 32% · moderate confidence
  • Passed Senate

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 D).

  • Mixed recorded votes

    2 passed, 1 failed in recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

The bill addresses regulations for prescription drugs and medication switching.

This measure establishes guidelines related to prescription drugs and the practice of switching medications. It aims to create a framework for how medication changes are handled.

Summary

To enact section 3902.65 of the Revised Code regarding prescription drugs and medication switching.

Bill Text

What changed in the latest version

6 added · 5 removed

Plain-language change summary

The latest version of Bill SB 160 now includes a list of senators who are cosponsoring the legislation, highlighting the support it has received from multiple lawmakers. Additionally, references to the committee report have been removed, which streamlines the text and focuses more on the bill itself. This change is significant as it strengthens the bill's visibility and emphasizes bipartisan support, making it clearer for the public and lawmakers alike.

→
Previous
Latest
As Reported by the Senate Financial Institutions, Insurance and Technology Committee 136th General Assembly Regular Session Sub.
As Passed by the Senate 136th General Assembly Regular Session Sub.
160 2025-2026 Senators Liston, Johnson To enact section 3902.65 of the Revised Code 1 regarding prescription drugs and medication 2 switching under health benefit plans.
160 2025-2026 Senators Liston, Johnson Cosponsors:
Senators Antonio, Blackshear, Cirino, Craig, DeMora, Hicks-Hudson, Patton, Reineke, Reynolds, Schaffer To enact section 3902.65 of the Revised Code 1 regarding prescription drugs and medication 2 switching under health benefit plans.
15 (B) Subject to divisions (C), (D), and (E) of this 16 section, a health plan issuer shall not do any of the following 17 during a health benefit plan year:
15 (B) Subject to divisions (C), (D), and (E) of this 16 section, a health plan issuer shall not do any of the following 17 Sub.
18 Sub.
160 Page 2 As Reported by the Senate Financial Institutions, Insurance and Technology Committee (1) Increase a covered person's cost sharing with respect 19 to a drug;
160 Page 2 As Passed by the Senate during a health benefit plan year:
18 (1) Increase a covered person's cost sharing with respect 19 to a drug;
44 (2) A health plan issuer permitting a covered person to 45 use the generically equivalent drug or interchangeable 46 Sub.
44 Sub.
160 Page 3 As Reported by the Senate Financial Institutions, Insurance and Technology Committee biological product instead of the prescribed drug;
160 Page 3 As Passed by the Senate (2) A health plan issuer permitting a covered person to 45 use the generically equivalent drug or interchangeable 46 biological product instead of the prescribed drug;
If a health plan issuer seeks to 69 take an action described in division (B) of this section for a 70 drug subject to such a price increase, it shall maintain 71 supporting documentation that justifies the action for a period 72 of three years after the effective date of the price increase 73 and shall provide the supporting documentation to the department 74 of insurance upon the department's request.
If a health plan issuer seeks to 69 take an action described in division (B) of this section for a 70 drug subject to such a price increase, it shall maintain 71 supporting documentation that justifies the action for a period 72 of three years after the effective date of the price increase 73 Sub.
75 Sub.
160 Page 4 As Reported by the Senate Financial Institutions, Insurance and Technology Committee (F) A violation of this section shall be considered an 76 unfair and deceptive practice in the business of insurance for 77 purposes of section 3901.21 of the Revised Code.
160 Page 4 As Passed by the Senate and shall provide the supporting documentation to the department 74 of insurance upon the department's request.
75 (F) A violation of this section shall be considered an 76 unfair and deceptive practice in the business of insurance for 77 purposes of section 3901.21 of the Revised Code.
View plain text versions (3)

Action History

  1. As Passed by the Senate

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 133 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (133)

133 members have not signed on to this bill.

Show all 133 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passed

Passed 33 Yea · 0 Nay
Party YeaNayPresentNot Voting
Republican 24000
Democratic 9000
Total 33000
% of votes cast 100%0%0%0%
How each member voted (33)
Member Party Vote
Beth Liston Democratic Yea
Casey Weinstein Democratic Yea
Catherine D. Ingram Democratic Yea
Hearcel F. Craig Democratic Yea
Kent Smith Democratic Yea
Nickie J. Antonio Democratic Yea
Paula Hicks-Hudson Democratic Yea
William P. DeMora Democratic Yea
Willis E. Blackshear, Jr. Democratic Yea
Al Cutrona Republican Yea
Al Landis Republican Yea
Andrew O. Brenner Republican Yea
Bill Reineke Republican Yea
Brian M. Chavez Republican Yea
George F. Lang Republican Yea
Jane M. Timken Republican Yea
Jerry C. Cirino Republican Yea
Kristina D. Roegner Republican Yea
Kyle Koehler Republican Yea
Louis W. Blessing, III Republican Yea
Mark Romanchuk Republican Yea
Michele Reynolds Republican Yea
Nathan H. Manning Republican Yea
Rob McColley Republican Yea
Sandra O'Brien Republican Yea
Shane Wilkin Republican Yea
Stephen A. Huffman Republican Yea
Steve Wilson Republican Yea
Susan Manchester Republican Yea
Terry Johnson Republican Yea
Theresa Gavarone Republican Yea
Thomas F. Patton Republican Yea
Tim Schaffer Republican Yea

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 160 do?
To enact section 3902.65 of the Revised Code regarding prescription drugs and medication switching.
Who sponsors SB 160?
SB 160 is sponsored by Beth Liston (Democratic).
What is the current status of SB 160?
This bill has passed the Senate. Introduced April 01, 2025. It now moves to the second chamber.
Where can I track SB 160?
Track SB 160 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 160

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 160

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →